It’s no secret amongst psychedelic investors that ATAI Life Sciences has built up an impressive portfolio of companies. Backed by household names such as Peter Thiel, Mike Novogratz, and Steve Jurvetson, investors have been scrambling to be a part of the nearly $200 million raised to date. When and where the company will list is…